These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3498899)

  • 41. Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations.
    Granoff DM; Daum RS
    J Pediatr; 1980 Nov; 97(5):854-60. PubMed ID: 7000999
    [No Abstract]   [Full Text] [Related]  

  • 42. Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients.
    Cates KL; Krause PJ; Murphy TV; Stutman HR; Granoff DM
    Pediatr Infect Dis J; 1987 Jun; 6(6):512-5. PubMed ID: 3497378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of three antibiotic regimens for eradication of Haemophilus influenzae type b from the pharynx of infants and children.
    Horner DB; McCracken GH; Ginsburg CM; Zweighaft TC
    Pediatrics; 1980 Jul; 66(1):136-8. PubMed ID: 6967582
    [No Abstract]   [Full Text] [Related]  

  • 44. Epiglottitis in adults: association with Haemophilus influenzae type b colonization and disease in children.
    Glode MP; Halsey NA; Murray M; Ballard TL; Barenkamp S
    Pediatr Infect Dis; 1984; 3(6):548-51. PubMed ID: 6393079
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ecchymotic cellulitis in infants: consider Haemophilus influenzae].
    Loras-Duclaux I; Floret D; Lachaux A; Descos B; Freney J; Hermier M
    Pediatrie; 1987; 42(7):527-9. PubMed ID: 3502178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Goldmann DA; Halsey N; Ambrosino D; Welborn C; Mather FJ; Willard JE; Sullivan B; Murray M; Johansen T
    J Pediatr; 1981 Mar; 98(3):485-91. PubMed ID: 7009819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunisation against Haemophilus influenzae type b.
    Levy M; Menzies R
    Aust J Public Health; 1995 Feb; 19(1):108. PubMed ID: 7734585
    [No Abstract]   [Full Text] [Related]  

  • 48. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Ambrosino D; Halsey N; Goldmann DA; Mather FJ; Russell R; Kamon J; Murray M; Band JD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):658-62. PubMed ID: 6607027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease.
    McCracken GH; Ginsburg CM; Zweighaft TC; Clahsen J
    Pediatrics; 1980 Jul; 66(1):17-21. PubMed ID: 6967586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [When should vaccination against Haemophilus influenzae type b take place?].
    Stickl HA
    Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
    [No Abstract]   [Full Text] [Related]  

  • 52. Preventing Haemophilus influenzae type b disease.
    Casto DT; Edwards DL
    Clin Pharm; 1985; 4(6):637-48. PubMed ID: 3907936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunisation against Haemophilus influenzae type b.
    Commun Dis Rep CDR Wkly; 1992 Sep; 2(39):177. PubMed ID: 1285115
    [No Abstract]   [Full Text] [Related]  

  • 54. Development of Haemophilus influenzae type b meningitis in a household contact treated with rifampin.
    Boies EG; Granoff DM; Squires JE; Barenkamp SJ
    Pediatrics; 1982 Jul; 70(1):141-2. PubMed ID: 6979733
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998-1999.
    Scheifele D; Halperin S
    Can Commun Dis Rep; 2000 Jun; 26(11):93-6. PubMed ID: 10920538
    [No Abstract]   [Full Text] [Related]  

  • 57. Point: recommendations for rifampin prophylaxis of Haemophilus infections by the Committee on Infectious Diseases of the American Academy of Pediatrics.
    Fulginiti VA
    Pediatr Infect Dis; 1982; 1(6):377-8. PubMed ID: 7163025
    [No Abstract]   [Full Text] [Related]  

  • 58. Decline of bone and joint infections attributable to haemophilus influenzae type b.
    Bowerman SG; Green NE; Mencio GA
    Clin Orthop Relat Res; 1997 Aug; (341):128-33. PubMed ID: 9269165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New immunization against H. influenzae type b.
    Mansell KA
    Pediatr Nurs; 1985; 11(6):433-5. PubMed ID: 3877268
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of chemoprophylaxis to prevent the spread of Hemophilus influenzae B in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1987 May; 316(19):1226-8. PubMed ID: 3494944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.